A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.
Clinical trial NCT04494984 · COMPLETED
Trial details
- NCT number
- NCT04494984
- Sponsor
- Inmunova S.A.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2020-11-23
- Enrollment
- 243
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.